A Temple-led research team headed by Walter J. Koch, PhD, the William Wikoff Smith Endowed Chair in Cardiovascular Medicine at the Lewis Katz School of Medicine at Temple University (LKSOM), Professor and Chair of Pharmacology at LKSOM, and Professor and Director of the Center for Translational Medicine at LKSOM, showed for the first time that blocking G protein-coupled receptor kinase 2 (GRK2) localization to mitochondria protects heart cells from ischemic injury and death, casting new light on GRK2 as a potential therapeutic target in post-injury heart failure. Dr. Koch was the senior investigator on the report, and the findings were published online in the journal Science Signaling. Medical Xpress provided coverage.
Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.
myTempleHealth
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH